Peyvandi, Flora

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

De Waele, Laure; Sakai, Kazuya; Mancini, Ilaria; Sinkovits, György; Falter, Tanja; Inoue, Takashi; Agosti, Pasquale; Rossmann, Heidi; Von Auer, Charis; Tersteeg, Claudia; De Meyer, Simon F; Joly, Bérangère S; Veyradier, Agnès; Coppo, Paul; Fijnheer, Rob; Peyvandi, Flora; Prohászka, Zoltán; Lämmle, Bernhard; Vanhoorelbeke, Karen (2024). Open ADAMTS13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 22(2), pp. 493-502. Wiley-Blackwell 10.1016/j.jtha.2023.10.014

Castaman, Giancarlo; Peyvandi, Flora; Kremer Hovinga, Johanna A; Schutgens, Roger E G; Robson, Susan; Moreno, Katya; Jiménez-Yuste, Víctor (2024). Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors. TH open, 8(1), e42-e54. Thieme 10.1055/s-0043-1777766

Scully, Marie; de la Rubia, Javier; Pavenski, Katerina; Metjian, Ara; Knöbl, Paul; Peyvandi, Flora; Cataland, Spero; Coppo, Paul; Kremer Hovinga, Johanna A; Minkue Mi Edou, Jessica; De Passos Sousa, Rui; Callewaert, Filip; Gunawardena, Sriya; Lin, Julie (2022). Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis, 20(12), pp. 2810-2822. Wiley-Blackwell 10.1111/jth.15892

Peyvandi, Flora; Cataland, Spero; Scully, Marie; Coppo, Paul; Knoebl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood advances, 5(8), pp. 2137-2141. American Society of Hematology 10.1182/bloodadvances.2020001834

Cuker, Adam; Cataland, Spero R; Coppo, Paul; de la Rubia, Javier; Friedman, Kenneth D; George, James N; Knoebl, Paul N; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Matsumoto, Masanori; Pavenski, Katerina; Peyvandi, Flora; Sakai, Kazuya; Sarode, Ravi; Thomas, Mari R; Tomiyama, Yoshiaki; Veyradier, Agnès; Westwood, John-Paul; Scully, Marie (2021). Redefining outcomes in immune TTP: an international working group consensus report. Blood, 137(14), pp. 1855-1861. American Society of Hematology 10.1182/blood.2020009150

Knoebl, Paul; Cataland, Spero; Peyvandi, Flora; Coppo, Paul; Scully, Marie; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2020). Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of thrombosis and haemostasis, 18(2), pp. 479-484. Wiley-Blackwell 10.1111/jth.14679

Scully, Marie; Cataland, Spero R; Peyvandi, Flora; Coppo, Paul; Knöbl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Callewaert, Filip; Biswas, Debjit; De Winter, Hilde; Zeldin, Robert K (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 380(4), pp. 335-346. Massachusetts Medical Society 10.1056/NEJMoa1806311

Peyvandi, Flora; Scully, Marie; Kremer Hovinga, Johanna Anna; Cataland, Spero; Knöbl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Mansouri Taleghani, Magnus; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. New England journal of medicine NEJM, 374(6), pp. 511-522. Massachusetts Medical Society MMS 10.1056/NEJMoa1505533

Cataland, Spero R; Peyvandi, Flora; Mannucci, Pier M; Lämmle, Bernhard; Kremer Hovinga, Johanna A; Machin, Samuel J; Scully, Marie; Rock, Gail; Gilbert, James C; Yang, Shangbin; Wu, Haifeng; Jilma, Bernd; Knoebl, Paul (2011). Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura. American journal of hematology, 87(4), pp. 430-2. New York, N.Y.: Wiley-Liss 10.1002/ajh.23106

This list was generated on Fri Mar 29 06:40:39 2024 CET.
Provide Feedback